NCT03890705 - Clinical Trial References

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Citation(s)

Ali M, Seuc A, Rahimi A, Festin M, Temmerman M
A global research agenda for family planning: results of an exercise for setting research priorities. Bull World Health Organ. 2014 Feb 1;92(2):93-8. doi: 10.2471/BLT.13.122242. Epub 2013 Nov 4.
El-Masry R et al
Unmet need for family planning among women in rural Egypt International Journal of Community Medicine and Public Health. 2018 Apr;5(4):1252-1261
Jackson E, Glasier A
Return of ovulation and menses in postpartum nonlactating women: a systematic review. Obstet Gynecol. 2011 Mar;117(3):657-62. doi: 10.1097/AOG.0b013e31820ce18c. Review.
Ministry of Health and Population [Egypt], El-Zanaty and Associates [Egypt], and ICF International
2015. Egypt Demographic and Health Survey 2014. Cairo, Egypt and Rockville, Maryland, USA: Ministry of Health and Population and ICF International.

Postpartum Family Planning Utilization and Associated Factors Among Women During the First Year After Childbirth in Assiut District

Clinical trial NCT03890705 - References